You are here

Industry News

Advamed Smart Brief

February 15, 2019
Sight Diagnostics, a firm that uses artificial intelligence in blood testing, has received $27.8 million from a Series C fund -More
February 15, 2019
Quest Diagnostics saw fourth-quarter 2018 revenues of $1.84 billion and net income of $127 million.  -More
February 15, 2019
A round of Series C funding raised $126 million for Chinese molecular diagnostics company Burning Rock.  -More
February 15, 2019
Medtronic and the Medical University of South Carolina are collaborating on value-based care efforts in joint surgery and oth -More
February 15, 2019
The FDA granted Foldax an investigational device exemption approval for an early feasibility study of its Tria surgical aorti -More
February 15, 2019
GI Dynamics has received Institutional Review Board approval to begin a pivotal trial of its EndoBarrier device.  -More
February 15, 2019
Tandem Diabetes Care has received FDA approval for its t:slim X2 insulin pump, an alternate controller enabled infusion pump  -More
February 15, 2019
Safe Medical Design has secured FDA clearance to commercialize its Signal Catheter in the US.  -More
February 15, 2019
Miraca Holdings subsidiary Fujirebio Diagnostics' Lumipulse G β-Amyloid Ratio quantitative in vitro diagnostic test for Alzhe -More
February 15, 2019
Hologic has received CE mark certification for its Aptima HIV-1 Quant Dx assay for use in qualitative diagnosis of HIV-1 infe -More

Industry News

Digital Journal
SAN DIEGO, CA - iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 13/074,209. The allowed patent includes 66 claims relating to multiple types of patient tests, wireless communications, plug-in modules, and user guides. The patent application is expected to issue in mid-2019...
Philips
AMSTERDAM, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures.  During increasingly complex interventions, clinicians need to quickly and easily visualize critical anatomy and identify changes to the patient during the procedure. Azurion with FlexArm includes a set of innovations that makes it easier for the clinician...
RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.